@article{Salman_Allahsan_Mahmood_Anam_Anwar_Afrose_Afrose_Uddin Sultan_Rahman_2012, title={New Drugs for Acute Heart Failure}, volume={7}, url={https://banglajol.info/index.php/UHJ/article/view/10208}, DOI={10.3329/uhj.v7i1.10208}, abstractNote={<p>Acute heart failure is a major health problem responsible for several million hospitalizations worldwide each year. Standard therapy has not changed for long time and includes diuretics and variable use of vasodilators or inotropes. Recently Nesiritide and Levosimendan are two drugs for the treatment of acute heart failure which have been approved by the Food and Drug Administration (FDA) and European Medicines Agency (EMEA), respectively. There was little concern that Nesiritide can worsen the renal failure but recent trials had abolished this concern.</p> <p>DOI: <a href="http://dx.doi.org/10.3329/uhj.v7i1.10208">http://dx.doi.org/10.3329/uhj.v7i1.10208</a></p> <p><em>UHJ </em>2011; 7(1): 35-38<strong><em></em></strong></p>}, number={1}, journal={University Heart Journal}, author={Salman, Mohammad and Allahsan, Syed and Mahmood, Manzoor and Anam, Md Khairul and Anwar, Shahed Mohammad and Afrose, Roksana and Afrose, Md Abu and Uddin Sultan, Md Ashraf and Rahman, Fazlur}, year={2012}, month={Mar.}, pages={35–38} }